Clinical Trials Arena September 19, 2024
Statistics show incidences of cancer are rising in younger demographics. Tailored therapies offer a solution – if clinical trial organisers can boost diversity
Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The rising incidence of cancer in individuals under 50 is alarming, with several cancers, including colorectal and breast cancer, showing notable increases in this demographic. This surge has brought to light the urgent need for tailored cancer therapies that consider the unique physiological, genetic, and environmental factors affecting younger patients. Simultaneously, it underscores the critical need for diversity in clinical trials to ensure that treatment options are effective for all populations.
Rising incidence of cancer in young adults
...Today's Sponsors
Today's Sponsor